Fast Acting Sublingual Technology (FAST™)
For medicines treating conditions, such as breakthrough pain, panic disorder, epilepsy, acute psychosis, and insomnia, rapid onset of action is a critical unmet need. This desirable attribute of providing quick relief of symptoms is not available with conventional orally disintegrating tablets currently on the market. Kashiv aims to fill this void with its proprietary technology for Rapid-Onset products.
The Kashiv technology is based on nano-amorphous and particle engineering technologies and offers a tremendous opportunity for rapid onset, especially for poorly soluble compounds. By presenting drugs in a sublingual or fast-dissolve formulation, the absorption process can start rapidly in the oral cavity and, additionally, reduce the loss of drug due to first-pass effect.